Another approved malaria medicine shows potential against COVID-19

An antimalarial is the latest drug that researchers have identified as a potential COVID-19 treatment. In a laboratory study, scientists found that atovaquone inhibited replication of SARS-CoV-2 in human lung cells. The effects occurred in vitro against Alpha, Beta, and Delta variants. Clinical trials are necessary to see whether it […]